chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Face is really flushed; Started running a fever; she's totally spent; She feels very weak, her whole body feels weak,; Is in extreme pain all through her stomach area; Face is really hot; Getting chills real bad; Lot of pain in the injection site, all the time since yesterday, severe pain; This spontaneous case was reported by a non-health professional and describes the occurrence of FLUSHING (Face is really flushed), ASTHENIA (She feels very weak, her whole body feels weak,), ABDOMINAL PAIN UPPER (Is in extreme pain all through her stomach area), FEELING HOT (Face is really hot) and CHILLS (Getting chills real bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A-1 and 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack (2 heart attacks) and Stent placement. Concurrent medical conditions included Blood pressure high.   On 10-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Aug-2021, the patient experienced ASTHENIA (She feels very weak, her whole body feels weak,), ABDOMINAL PAIN UPPER (Is in extreme pain all through her stomach area), FEELING HOT (Face is really hot), CHILLS (Getting chills real bad), VACCINATION SITE PAIN (Lot of pain in the injection site, all the time since yesterday, severe pain) and FATIGUE (she's totally spent). On 09-Aug-2021 at 10:00 PM, the patient experienced PYREXIA (Started running a fever). On 10-Aug-2021, the patient experienced FLUSHING (Face is really flushed). The patient was treated with Manual therapy (Cold compresses  in face, neck and arm to try to bring the fever down) for Pyrexia. At the time of the report, FLUSHING (Face is really flushed), ASTHENIA (She feels very weak, her whole body feels weak,), ABDOMINAL PAIN UPPER (Is in extreme pain all through her stomach area), FEELING HOT (Face is really hot), VACCINATION SITE PAIN (Lot of pain in the injection site, all the time since yesterday, severe pain), PYREXIA (Started running a fever) and FATIGUE (she's totally spent) had not resolved and CHILLS (Getting chills real bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Aug-2021, Body temperature: 101.5 (High) At 10 pm-101.5 Degree Celsius. On 10-Aug-2021, Body temperature: 101.1 (High) 101.1 Degree Celsius.         Concomitant medication includes high blood pressure medication.  The patient had no adverse events after first dose of vaccine.  No treatment medications were reported
Tender and sore in elbow and forearm for 2 weeks. Now it is a high level ache with scorching, searing, ripping feeling pain off and on. Taking ibprofrin, icing, wrapping and anything else I can think of to relieve the pain. Can not bend the elbow ( left), without excruciating pain. Can't sleep, going on 3rd night.
Localized erythema Left shoulder and axillary area.  Lymphadenopathy.
vasovagal syncope - lasted 90 seconds, then gave juice and crackers, waiting 5 minutes, patient was back to baseline and finished observation period
rash on arms, abd, back (maculopapular and redness).  Treated with hydroxazine, prednisone burst (50mg po qd for 5 days), and famotidine 20 mg twice daily for 5 days.
Pt experienced varicella onset on 12/04/00.  This is to report chicken pox in previously vaccinated pt.
This case was reported by a physician and described the occurrence of aphasia in a 46-year-old female subject who was vaccinated with Flulaval (GlaxoSmithKline). The subject's medical history, concurrent medications were not reported. Information regarding previous immunization with influenza virus vaccine was not provided. The reporting physician did not have the subject's chart with him at the time of the call. On 15 November 2007 at 8:00 a.m., the subject received unspecified dose of Flulaval (.5 ml, unknown). On 15 November 2007, within a few minutes of receipt of Flulaval, the subject became "unresponsive." The physician reported that the subject's eyes were open but she was no longer able to speak. The physician described the subject was "unresponsiveness or aphaisiac". The subject's vital signs were stable and the subject did not pass out. Emergency medical services was called and the subject was taken to the hospital. The reporting physician has spoken with the emergency room physician and was told the subject was still in this "state" and they plan to admit her to the hospital. The reporting physician also considered the events to be disabling. At the time of reporting the events were unresolved.
headache after the 1st dose; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (headache after the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache after the 1st dose). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter.   This case was linked to MOD-2022-645572, MOD-2022-645571.   Reporter did not allow further contact
After an hour of the vaccine I had pain and bruising pain in my left arm. After a poor night's sleep with pain throughout the night I woke feeling headache, nausea, dizziness, tired, chills as well as the arm pain. With ibuprofen some symptoms have eased but I had to stay in bed for the whole morning. Almost recovered 24 hours after vaccination but it was brutal.
developed Polycythemia Vera; my liver is giving me trouble; increased my pain level by double; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  An adult female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pain" (ongoing). The patient's concomitant medications were not reported. The following information was reported: POLYCYTHAEMIA VERA (medically significant), outcome "unknown", described as "developed Polycythemia Vera"; LIVER DISORDER (non-serious), outcome "unknown", described as "my liver is giving me trouble"; PAIN (non-serious), outcome "unknown", described as "increased my pain level by double". Clinical course: Patient had watched that vaccine put her sister through, and she hates it. It had also increased her pain level by double. Suddenly her liver was giving her trouble. And she developed Polycythemia Vera after taking it as well. And it changes their DNA. As well as the fact that it had killed a lot of people by the problems it caused them.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s): US-PFIZER INC-202300200346 same reporter/drug, different patient/event.
Left shoulder local reaction 5cm induration. Treatment KEFLEX 500mg one PO 3x daily for 10 days.
Body Aches, Tiredness, Severe Headaches TX-Husband took her to the Urgent Care-5 Jan 2021 two injections given to her-Toradol, Zofran, Iv therapy also, prescription for Urrelvy-for migraines-she didn't fill it yet
Significantly increased tinnitus. Previously mild hyperacusis and ear pain greatly increased. Non stop ear pain and ringing since receiving the first dose of the vaccine. Started within 24 hours and became progressively worse over the following weeks. Has remained in worse state, now 3+ months later.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown ages and genders. On unknown dates, the patients were vaccinated with improperly stored GARDASIL 9 (lot # L048237, expiry date: 08-MAY-2017; lot # L024993, expiry date: 17-OCT-2017; lot # reported as L037554, expiry date: 25-DEC-2017). No adverse effect reported. The outcome of the events was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 5 yr old white female with no allergies or medical history who on 16Oct00 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live (lot 634506/1770J). Concomitant therapy the same day included a first dose SC in the left arm of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 633751/0987K) and a second dose IM in the left thigh of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (crm197) (PREVNAR) (lot472042). There was no illness at the time of vaccination. On 22Apr05, the pt developed breakthrough varicella which was described as "red papular; few scattered on body, one crusty" after being exposed to another previously vaccinated classmate that contracted chickenpox (WAES0504USA01510). Unspecified medical attention was sought. A product quality complaint was not involved. Follow up information was received from the physician who indicated that on 22Apr05, at 13.50, the pt developed varicella disease. There were no labs done and there were no complications. The pt was not seen back in the office but it was noted that she did recover. No further information is available.
Headache FATIGUE DAY 1-INJECTION SITE PAIN/SWELLING DAY 2-HEADACHE DAY 3-HEADACHE/FATIGUE DAY 4- FATIGUE
Chest pain started 1 day after each vaccine dose, continued for 2-3 days after onset. Heavy squeezing pain felt mostly on the left side, sometimes on right, with no radiation down the arm. Pain prevented falling asleep. No exercise intolerance. Pain resolved and absent since 3 days post second dose. Heart rate 77 bpm, O2 sat 98% (6/18/21)
Approximately 7 days after vaccination, a delayed reaction. My upper arm became itchy, red and hot.  Not painful.  This is day three of the reaction and I believe it might be getting  somewhat better.  I  have not had the need to medical intervention or medication.
Severe shoulder pain, abdominal/intestinal pain, nausea, fatigue; started 16 hours after receding injection; resolved 2 days after vaccination; took ibuprofen, pepto bismal to help symptoms
Patient had pain and redness at injection site as well as headache, fever, and chills.  When she came back the following day, the fever had gone down and the headache had dulled.  We suggested Hydrocortisone for the inflammation at injection site.
Developed acute uveitis several days after administration. Last uveitis flare up was 8 years prior.  Cleared up with prescribed steroid eye drops. Subsequently (within a few days following vaccine administration) developed what appears to have been erythema multiforme on my right hand (affecting index & middle fingers) - did not initially know what this was until recent research - lasted several months - self treated with lotions, etc. No history of similar issues. Finally, several days after uveitis, developed significant sciatica (with no previous history of such). Sciatica treated with multiple medication (including oral steroids), but lingering sciatica symptoms still persist at this time (6 months after onset). Based on timing and issues, believe all inflammation related issues are directly related to the vaccine.
45-year-old female with history of craniopharyngioma and central hypothyroidism, asthmatic bronchitis and obesity presents today for follow-up on Covid. Patient was exposed at work. She developed symptoms 4-5 days ago and tested Positive covid on 11/12/2021 at work, mostly dry cough-occasionally productive, sore throat, chills, throat tightness, shortness of breath, sinus congestion, nasal congestion, patient feels almost 100 % better but wants chest x-ray done.
Swelling of glands, tenderness at site of inoculation and glands, and fatigue.
SYMPTOMS STARTED MORNING OF 1/18: BODY ACHES, CHILLS. 12MD FEVER (101);2PM NAUSEA; AT NIGHT, HEADACHE AND NAUSEA. TUESDAY 1/19, MORNING NAUSEA. FELT BETTER TUESDAY AFTERNOON.
Note - patient was vaccinated for chickenpox in childhood with attenuated live vaccine and never infected with chickenpox previously.  On Oct 29, 2021, patient received Moderna COVID booster vaccine. On Oct 30, 2021, patient began experiencing neuropathic pain in R gluteus. On Oct 31, 2021, blistering rash appeared on patient's R gluteal dermatome, and several lesions appears on patient's torso, scalp, and face, accompanied by pain. Lesions continued to appear on patient's torso and extremities (arms, legs) over the next several days (>20 lesions on various, non-gluteal sites). Patient began taking oral valacyclovir treatment on Nov 2, 2021 and was instructed to quarantine beginning on those dates. On Nov 4, 2021, VZV PCR testing on facial and gluteal lesion was positive for VZV, confirming disseminated zoster. As of reporting date (Nov 9, 2021), patient has not recovered
- On day 2 following the should I had a Cough that last for 12 days.    - day 1 following the shot I was extremely tired for 8 days.  I- 10 hours after getting the shot I felt flu like symptoms  that lasted for 1.5 days.
Immediately after receiving HPV immunization in left shoulder patient reported ringing in the ears , slumped backwards and while lying on the exam table had brief tonic -clonic movement of extremities with eyes rolling and while seizing she was unresponsive for about 20-30 seconds. I was called into exam room, my medical assistant and patient was clammy, pale but came to and became responsive. Her vital signs were assessed and were significant for tachycardia 88 bpm. She rested with lower extremities elevated, then was slowly raised up to sitting position and accepted water , then after 20 minutes a bottle of pediasure ( she did have breakfast that morning but said she felt hungry in the office while at her well checkup). Patient was observed for 30 min following the episode and then sent home with her mother.
Headache, chills/shakiness, nausea, vomiting, itchiness all over, very red sore and hard lump on arm.
Acquired Thrombotic Thrombocytopenic Purpura; This is a literature report.  A 80 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as unk, single (second dose) for covid-19 immunisation. Relevant medical history included: "Hypertension" (ongoing); "type II diabetes mellitus" (ongoing); "hyperlipidemia" (ongoing); "gout" (ongoing); "iron deficiency anemia" (ongoing). The patient's concomitant medications were not reported. Past drug history included: Bnt162b2 for COVID-19 Vaccination, reaction(s): "No adverse event". The following information was reported: THROMBOTIC THROMBOCYTOPENIC PURPURA (medically significant), outcome "recovered", described as "Acquired Thrombotic Thrombocytopenic Purpura". Symptoms included generalized weakness, malaise. The patient underwent the following laboratory tests and procedures: adamts13 activity assay: less than 2; autoantibody test: 182 %. Therapeutic measures were taken as a result of thrombotic thrombocytopenic purpura including Plasma exchange, corticosteroids, rituximab.; Sender's Comments: Based on plausible temporal relationship the causal role of the BNT162B2 Vaccination cannot be excluded for reported event.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 10-OCT-2012, the patient was inoculated with ZOSTAVAX bat a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 07-JAN-2015, the patient was treated at a family health care facility for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Rapid heart beat and pulse; Fever; Diarrhea; Lightheadedness; This spontaneous case was reported by a physician and describes the occurrence of HEART RATE INCREASED (Rapid heart beat and pulse), PYREXIA (Fever), DIARRHOEA (Diarrhea) and DIZZINESS (Lightheadedness) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heart beat and pulse), PYREXIA (Fever), DIARRHOEA (Diarrhea) and DIZZINESS (Lightheadedness). At the time of the report, HEART RATE INCREASED (Rapid heart beat and pulse), PYREXIA (Fever), DIARRHOEA (Diarrhea) and DIZZINESS (Lightheadedness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100-101 100-101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jan-2021: New events added
Information was received from a L.P.N. regarding 47 year old female patient with COPD. On 09-OCT-2013, the patient was vaccinated with PNEUMOVAX23 (Lot # J004387, expiration 04-JAN-2015), 0.5 ml, intramuscular in the left arm. Concomitant therapies included amitriptyline hydrochloride, buspirone hydrochloride, IMITREX, potassium (unspecified), CLARITIN, naproxen and ZOLOFT. On 09-Oct-2013, the patient was also vaccinated with FLUZONE via right arm. The nurse reported that the patient experienced rash, hives and itching of both her arms and shoulders after receiving the PNEUMOVAX23 on 09-OCT-2011. On 11-OCT-2013, the patient was evaluated back in the office and was diagnosed with atopic dermatitis. Treatment included an unspecified skin moisturizer. At the time of this report the outcome of rash, atopic dermatitis, itching, and hives both arms was reported as recovered. Additional information has been requested.
Fainted about 15 to 20 minutes after dose; This is a spontaneous report from a contactable consumer (patient himself). A 24-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in the right arm on 17Apr2021 at 11:15 AM (Batch/Lot Number: ERB8729) as a single dose for COVID-19 immunization. The patient had no medical history. The patient had no known allergies. Concomitant medication included diphenhydramine taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. The patient had no COVID-19 prior vaccination. The patient was not tested for COVID-19 post vaccination. On 17Apr2021 at 11:30 AM, the patient fainted about 15 to 20 minutes after dose. The patient did not receive any treatment for the adverse event (AE). The patient recovered from the event on an unspecified date.
Passed out after receiving a booster shot; Hit their head and neck on a dishwasher causing injury; Hit their head and neck on a dishwasher causing injury; This is a spontaneous report from a non-contactable consumer (patient). A 74-year-old (non-pregnant) female consumer reported that she received the third booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number not provided) on an unspecified date (at the age of 74-year-old) at a single dose for COVID-19 immunisation. The patient previously received the first and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot numbers unknown) on unspecified dates, at single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient passed out after receiving a booster shot and hit her head and neck on a dishwasher causing injury. The event required Emergency Room visit. The event was not resolved. No seriousness was provided.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.
cough, body aches, fever--COVID +, afib, tachycardia, acute coronary syndrome
Generalized weakness. Found on floor twice by daughter, brought to ED and he was admitted for observation
Admit for COVID pna.Tested positive PTA 8/11 and received cefuroxime and monoclonal ab therapy. Fully vaccinated 3/2021. Updrafts, steroids, rocephin and zitromax, heparin gtt given possibility of PE. Outside of window for antiviral therapies. Course complicated by encephalopathy and LE hemotoma from heparin. Weaned to RA by 8/24 and condition improving. DC'd rehab.
Arm was swollen, hard and red, also had bruise in the center of the deltoid area. The pt's left ear was also swollen and red.
presented as a direct transfer from ED for the management of neutropenic fever and was found to have a UTI and COVID-19 infection.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient received vaccinations with improperly stored VARIVAX dose number 1 on 14-FEB-2014 and dose number 2 on 09-MAY-2014, both from lot # H018451 with expiry date on 09-OCT-2014 (dose unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review of records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Site of the injection, the arm has a small concaved spot.  Limited mobility, pain.  Was seen by her physician, county health officer.
9;18 through out the night nausea and once puked 9/19 5pm headache and puked. went to laydown and is still sleeping ate a tiny bit of food but little apatite
Tested positive for COVID-19 on 9/5/21 via PCR;  Admitted to hospital on 9/5/21;  Died on 9/10/21.